Mylan to acquire Indian subsidiary Matrix
This article was originally published in Scrip
Executive Summary
Mylan plans to acquire the remaining public shareholding in its Indian subsidiary, Matrix Laboratories, for about $133 million, through a voluntary delisting offer.